First Manhattan

First Manhattan’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

First Manhattan’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$443	–	1757
2022 Q4	$443	Hold	500	–	–	﹤0.01%	1613
2022 Q3	$0	Hold	500	–	–	﹤0.01%	1716
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	1529
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	1570
2021 Q4	$2K	Hold	500	–	–	﹤0.01%	1502
2021 Q3	$3K	Hold	500	–	–	﹤0.01%	1505
2021 Q2	$4K	Hold	500	–	–	﹤0.01%	1459
2021 Q1	$4K	Hold	500	–	–	﹤0.01%	1388
2020 Q4	$3K	Hold	500	–	–	﹤0.01%	1269
2020 Q3	$5K	Sell	500 -1,000	-67%	-$9.15K	﹤0.01%	1208
2020 Q2	$9K	Buy	+1,500	New	+$5.74K	﹤0.01%	1181

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return